The Cochrane Breast Cancer group's objective is to provide the best source of accurate and up-to-date information, especially about the prevention, early detection, treatments, follow-up care and supportive practices for women diagnosed with breast cancer.
The Cochrane Childhood Cancer group encourages and coordinates the conduct of systematic reviews on interventions and diagnosis for cancer in children and young adults with respect to prevention, treatment, diagnosis, supportive care, psychosocial care, palliative and terminal care, nursing care and late effects of treatment.
The Cochrane Gynaecological, Neuro-oncology and Orphan Cancers group are committed to providing reliable evidence required to make important decisions on issues concerning Gynaecological cancers, Neuro-oncology and related topics.
The Cochrane Haematological Malignancies group sums up evidence for diagnosis and treatment of adults with haematological diseases.The main focus is on leukaemia and lymphoma but the care of those suffering from other haematological diseases like aplastic anaemia is included in the wider scope of the group. In addition, the group evaluates interventions affecting the haematological cell system like stem cell transplantation and haemotopoetic growth factors. Finally supportive care and the management of haematological diseases is also within the Cochrane Haematological Malignancies's scope.
The Cochrane Lung Cancer group works on topics ranging from screening to chemotherapy and palliative radiotherapy.
The Cochrane Urology group mission is to conduct and disseminate systematic reviews of health care interventions and diagnostic accuracy for prostatic diseases, male sexual dysfunction, urology-related renal topics and urologic cancers. Evidence is primarily from randomized controlled trials.